Loading stock data…
XRAY
$10.47+0.21 (+2.05%)
After Hours$10.47+0.00 (+0.00%)· Last close Jun 9
DENTSPLY SIRONA Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DENTSPLY SIRONA Inc. in the Healthcare sector is trading at $10.47. Wall Street consensus targets $13.40 (15 analysts), implying a +28.0% move over the next 12 months. The stock is currently near its 52-week low of $9.41, remaining 12.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +28.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$10.47
Potential Downside
0%
Whystock Fair Value$10.47
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Hold
Mean target$13.40+28.0%
Range$9.00 – $17.00
Fundamentals
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Tech...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
4.58%
ROE
Average efficiency. Growth may require heavy reinvestment.
-47.65%
Volume
Today's trading volume
5.48M
Recent News
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Dentsply Sirona’s Expanded Nashville Dental Partnership Could Impact DENTSPLY SIRONA (XRAY) Investors
Dentsply Sirona Inc. recently expanded its U.S. distribution footprint by partnering with Nashville Dental Inc., adding its full portfolio of connected digital dentistry technologies to Nashville Dental’s nine‑state coverage across the Southeast and Mid-Atlantic. This move deepens Dentsply Sirona’s indirect channel presence while keeping service and installation local, potentially making its integrated digital workflows easier for more practices to adopt. We’ll now examine how this broader...
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with service-sector prices rising at their fastest pace in four years.